In Escherichia coli, osmoregulated periplasmic glucans (OPGs) are highly substituted by phosphoglycerol, phosphoethanolamine and succinyl residues. A two-step model was proposed to account for phosphoglycerol substitution: first, the membrane-bound phosphoglycerol transferase I transfers residues from membrane phosphatidylglycerol to nascent OPG molecules; second, the periplasmic phosphoglycerol transferase II swaps residues from one OPG molecule to another. Gene opgB was reported to encode phosphoglycerol transferase I. In this study, we demonstrate that the periplasmic enzyme II is a soluble form of the membrane-bound enzyme I. In addition, timing of OPG substitution was investigated. OPG substitution by succinyl residues occurs rapidly, probably during the backbone polymerization, whereas phosphoglycerol addition is a very progressive process. Thus, both phosphoglycerol transferase activities appear biologically necessary for complete OPG substitution.
INTRODUCTION
Escherichia coli, like other Gram-negative bacteria, accumulates in its periplasmic space large amounts of short glucans (5-12 glucose units) in response to low osmolarity of the growth medium (Bohin & Lacroix, 2006) . In E. coli, osmoregulated periplasmic glucans (OPGs) consist of a linear backbone made of b-1,2-linked glucose units to which several b-1,6-linkage branches are added. This backbone is highly substituted by sn-1-phosphoglycerol, by phosphoethanolamine residues derived from membrane phospholipids, and by O-succinyl ester of unknown origin (Kennedy, 1996) . OPGs were described for the first time in E. coli by E. P. Kennedy and his coworkers during their study of phospholipid turnover (Van Golde et al., 1973) , and they called them 'membrane-derived oligosaccharides' (MDOs) because of the membrane origin of the phosphoglycerol substituents.
Four genes are known to participate in OPG biosynthesis: two are needed for formation of the backbone (opgGH; Lacroix et al., 1991) and two are needed for its substitution by phosphoglycerol (opgB; Jackson et al., 1984; Lanfroy & Bohin, 1993) and succinyl residues (opgC; Lacroix et al., 1999) . Phosphatidylethanolamine, exogenously added to intact cells, was shown to be a source of phosphoethanolamine residues that are transferred to OPGs (Miller & Kennedy, 1987) , but this activity was not further characterized because attempts to develop an in vitro assay were unsuccessful, and its gene remained unidentified. Actually, only two enzyme activities have been accurately defined in vitro, both of them being involved in the phosphoglycerol substitution of OPGs.
The first described phosphoglycerol transferase was a soluble protein found in the periplasmic space (Goldberg et al., 1981) . This enzyme was partially purified and has an apparent molecular mass of 56 000 in gel permeation chromatography. In vitro, it catalyses the transfer of phosphoglycerol to unsubstituted OPG molecules or model b-glucosides in the presence of Mn 2+ . However, the enzyme is unable to use phosphatidylglycerol as the donor substrate, but it catalyses the interchange of phosphoglycerol residues between OPG molecules. Moreover, at low concentration of acceptor, the enzyme acts as a cyclase with the liberation of cyclic phosphoglycerol.
The second described activity was a membrane-bound phosphoglycerol transferase. In vitro, the enzyme catalyses the transfer of phosphoglycerol residues from phosphatidylglycerol to OPGs or to synthetic b-glucoside acceptors such as arbutin (Jackson & Kennedy, 1983) . In vivo, the transfer occurs also to arbutin, which is not transported or degraded by the bacterium. Thus, this enzyme should have its catalytic site present on the periplasmic side of the cytoplasmic membrane . Jackson & Kennedy (1983) proposed a two-step model in which phosphoglycerol residues would be first transferred by the membrane-bound phosphoglycerol transferase I to newly synthesized glucans, still linked to the membrane. Then, the periplasmic phosphoglycerol transferase II would transfer those residues from one molecule of OPG (potentially still an acceptor in the first step) to another already liberated in the periplasmic space.
Mutants in the phosphoglycerol transfer (Jackson et al., 1984) were isolated on the basis of the toxic accumulation of diacylglycerol resulting from addition of arbutin to the growth medium of a diacylglycerol kinase mutant (dgk). As expected from the model, the OPGs synthesized by these opgB mutants were devoid of phosphoglycerol. Moreover, crude extracts from an opgB strain still possessed the ability to remove phosphoglycerol residues from wild-type OPGs.
The opgB gene was cloned and localized immediately adjacent to the dnaTC operon (Lanfroy & Bohin, 1993) . Further characterization of the opgB gene product was hindered by an unusual instability of the protein, most of which was recovered in a soluble form. Thus, we decided to re-examine the relationship between the two enzymes.
METHODS
Bacterial strains and media. The E. coli K-12 strains and plasmids used in this study are listed in Table 1 . Bacteria were grown at 37 uC with vigorous shaking in Luria broth (LB) or in minimal medium 63 supplemented with the required metabolites and glucose as the carbon source (Miller, 1992) . Solid media were obtained by adding agar (15 g l 21 ). When low-osmolarity medium was required, lowosmolarity medium (LOS) or LB without NaCl was used (Lacroix et al., 1989) . Antibiotics in media were used at the following concentrations: ampicillin, 50 mg ml 21 ; kanamycin, 50 mg ml 21 ; and tetracycline, 25 mg ml 21 . X-Gal was used in media at the concentration of 20 mg ml 21 .
Transduction and transformation. Transduction by phage P1vir was carried out according to Miller (1992) . E. coli cells were made competent by the rubidium chloride technique (Miller, 1992) .
Recombinant DNA techniques. Standard procedures (Sambrook et al., 1989) were used for l DNA isolation, large-scale plasmid isolation and rapid analysis of recombinant plasmids. Restriction endonucleases (Biolabs), large (Klenow) fragment of DNA polymerase I, S1 nuclease and ligase of phage T4 (Gibco-BRL) were used according to the manufacturer's recommendations. Exonuclease III was used according to the method of Debarbieux et al. (1997) .
DNA sequencing. Double-stranded opgB-blaM fusion plasmid DNAs were sequenced according to the Sequenase version 2.0 sequencing protocol (United States Biochemicals). The sequencing primer hybridizing at the 59 end of blaM (59-CCCACTCGTGCAC-CCAACT-39) was produced by Eurogentec.
Plasmid construction. The opgB gene was cloned as follows. l phage 8D1 DNA (Kohara et al., 1987) was first digested by SalI and KpnI ( Fig. 1) and the 3.6 kb DNA fragment containing the opgB gene was cloned into pBGS18 digested by SalI and KpnI to give pNF601. Then, the 2.6 kb HindIII DNA fragment of pNF601 was cloned into the HindIII site of pYZ4 (Debarbieux et al., 1997) to give pNF604. For the construction of random fusion plasmids, the 3.2 kb SphI DNA fragment of pNF601 was cloned into the SphI site of pNF150 (Loubens et al., 1993) , thus placing the opgB gene upstream of a truncated version of blaM (pNF673). The resulting plasmid, pNF673, was digested by SstI and SalI before digestion by exonuclease III, allowing deletions of the opgB gene only. Two additional opgB-blaM fusions were generated as follows by direct cloning into restriction sites. For pNF710, plasmid pNF601 was digested by KpnI and DraI and the 1.2 kb DNA fragment was cloned into pNF150 digested by KpnI and EcoRV. For pNF717, plasmid pNF601 was digested by EcoRI and BamHI, blunt-ended by the large fragment of DNA polymerase I, and the 2.7 kb DNA fragment was cloned into pNF150 digested by XbaI and blunt-ended by the large fragment of DNA polymerase I. For the expression of a truncated version of OpgB deleted of its two first transmembrane segments, pNF604 was digested by BamHI and blunt-ended by S1 nuclease, thus deleting a 340 bp DNA fragment to give pNF721. Plasmid pNF596, in which opgB is fused to blaM after the codon for residue 164, was similarly engineered to give pNF723. ). OPGs were extracted as described previously (Lacroix et al., 1989) and purified as follows. Pyridine extract was chromatographed on a Biogel P4 column (Bio-Rad). The column (1.5 cm665 cm) was equilibrated with 0.5 % acetic acid and eluted at a rate of 15 ml h 21 in the same buffer. Fractions (1.5 ml) containing OPGs were pooled, concentrated by rotary evaporation and desalted on a Biogel P2 column (Bio-Rad). Fractions containing OPGs were pooled and concentrated by rotary evaporation. These OPGs were used in the cyclic phosphoglycerol assay (see below) as a donor substrate of phosphoglycerol.
Assay of OPG substitution with [2-
3 H]glycerol. The glycerol auxotrophic strain BB2636 and its opgB derivative (NFB758) were grown in LOS medium (5 ml) complemented with 1.35 mM [2-
3 H]glycerol (296 MBq mmol 21 ) and OPGs were extracted from overnight cultures as described previously (Lacroix et al., 1989) .
Determination of neutral and anionic characteristics of OPGs.
Cultures (5 ml) of DF214 were grown in LOS medium; 0.24 mM D-[U-
C]glucose (125 MBq mmol
21 ) was added in the exponential growth phase for various times and the reaction was stopped by adding 1 ml 30 % TCA. OPGs were then extracted and purified as described above and desalted on a PD10 column (Pharmacia Biotech) equilibrated with Tris/HCl 10 mM (pH 7.4). Fractions containing OPGs were pooled and chromatographed on a DEAE-Sephacel column (1.5 cm638 cm, Pharmacia Biotech) equilibrated with Tris/ HCl 10 mM (pH 7.4) and eluted with the same buffer containing increasing concentrations of NaCl ranging from 0 M to 1 M by steps of 0.05 M. A volume of 60 ml was used for each NaCl concentration and the volume of each collected fraction was 4 ml. When necessary, fractions of one peak were pooled and the succinyl substituents of OPGs were removed by incubation in 100 mM KOH for 2 h at 30 uC. Treated OPGs were then desalted and chromatographed on a DEAESephacel column as previously described.
Determination of ampicillin resistance of cells expressing blactamase fusion proteins. The ampicillin resistance of individual cells of NFB732 containing opgB-blaM fusion plasmids was determined according to Debarbieux et al. (1997) .
Cellular location of fusion proteins. Soluble or membrane-bound location of fusion proteins was determined according to Loubens et al. (1993) .
Partial purification of periplasmic proteins. Cells of strain 678 and derivatives were grown in LB without NaCl (100 ml). When cell densities reached 6610 8 cells ml
21
, periplasmic protein release was performed according to Loubens et al. (1993) . One hundred microlitres of BSA (50 mg ml
) was added to the periplasmic protein-containing supernatant as a tracer. This supernatant was chromatographed on Sephadex G-50 (1 cm618 cm) at 4 uC. Protein content of each fraction of 1 ml was measured as A 260 . Fractions containing proteins (7 ml) were pooled, partially purified and concentrated in Macrosep 30K tubes (Pall Filtron) at 3000 g for 5 h at 4 uC to a final volume of 350 ml. Cyclic phosphoglycerol assay. The method was adapted from Goldberg et al. (1981) . The final volume of reaction was 200 ml. After addition of periplasmic proteins (145 ml), samples were incubated at 37 uC for various times. The reactions were stopped by the addition of 1 ml charcoal suspension (Norit A, 20 mg ml 21 in distilled water). Samples were then vigorously agitated for 10 min. Unlike OPGs, cyclic phosphoglycerol is not adsorbed on charcoal. Thus, the charcoal-containing labelled OPGs was removed by centrifugation at 8000 g for 10 min. Radioactivity of the supernatant, containing [2-
3 H]glycerol-labelled cyclic phosphoglycerol liberated by the enzyme, was counted. Activity was calculated according to Goldberg et al. (1981) .
RESULTS AND DISCUSSION

Nucleotide sequence analysis of the opgB gene
The open reading frame of the opgB gene encodes a 763 amino acid polypeptide beginning and ending at a TTG codon and a TAA codon respectively. Seven nucleotides upstream of the TTG codon is found a putative ribosomebinding site (Fig. 1) . Eleven nucleotides downstream from the TAA is found a putative transcription terminator consisting of two inverted repeats of 12 nucleotides. Transcription analysis of the dnaTCyjjA operon, located upstream of the opgB gene, was reported (Masai & Arai, 1988) . The majority of the transcripts pass through a terminator downstream of dnaC and terminate downstream of yjjA (Fig. 1) . When introduced into strain NFB732 (opgB214 : : Tn10), plasmids pNF601 (SphI-SalI) and pNF604 (HindIII-SalI) (Fig. 1) complemented the phosphoglycerol transferase I defect (data not shown), indicating that the 2.6 kb insert of pNF604 contains the full-length opgB coding sequence. The HindIII site is located close to the ribosome-binding site, suggesting that in pNF604 the opgB promoter is missing and the open reading frame is transcribed from the lac promoter of the pYZ4 vector. For location of the promoter, two deletions of one opgB-blaM plasmid fusion (protein fusion point downstream of amino acid 164, see below) were performed. Strains harbouring plasmids with the XmnI deletion (removing the lac promoter of the plasmid vector) or plasmids with the SphI-HindIII deletion (see Fig. 1 ) remained ampicillin resistant. Strains harbouring plasmids with both deletions became ampicillin sensitive, indicating that the opgB promoter is located upstream of the HindIII site. Taken together, these data suggested that the opgB promoter is located between the yjjA terminator and the HindIII site (Fig. 1) .
Amino acid sequence analysis of OpgB and prediction of its topology
OpgB is a protein with a deduced molecular mass of 85 494 Da. This is in agreement with the apparent molecular mass of 84 000 Da calculated from SDS-PAGE during the analysis of gene products located at the vicinity of the dnaTCyjjA operon (Masai & Arai, 1988) . The deduced protein OpgB was found to be a member of the alkaline phosphatase superfamily of metalloenzymes (Galperin et al., 1998) and its amino acids 163-448 form a conserved sulfatase domain (Pfam00884, http://pfam. jouy.inra.fr, Bateman et al., 2002) . The dense alignment surface (DAS) method (http://www.sbc.su.se/~miklos/DAS, Cserzo et al., 1997) and the TopPred II algorithm (http:// bioweb.pasteur.fr/seqanal/interfaces/toppred.html, Claros & von Heijne, 1994) allowed the prediction of the same three or four membrane-spanning segments in the first 124 amino acids (Fig. 1) . We have no evidence for the existence of the putative transmembrane segment located in the vicinity of the N-terminal part of OpgB, which is not represented in Fig. 1 . Four consecutive arginine residues are found in a 9 amino acid sequence between the two last transmembrane segments. Taking into account the 'positive inside' rule, one can deduce that the hydrophilic C-terminal part of the protein (amino acids 125-763) is responsible for its catalytic activity on the periplasmic face of the membrane . To test the validity of this model (Fig. 1) , blactamase was used as a topological reporter.
Analysis of opgB-blaM gene fusions
Twenty-three in-frame opgB-blaM fusions were obtained after exonuclease III digestion (see Methods). The position of the b-lactamase moiety (cytoplasmic or periplasmic) was determined for each fusion by streaking the colonies, up to individual cells, on LB agar plates containing 50 mg ampicillin ml
21
. All the fusions conferred resistance on individual cells, indicating that these strains have a blactamase moiety in the periplasmic space. The fusion point between the opgB and truncated blaM genes of the 23 fusions was determined by DNA sequencing. Then, nine of them, regularly spaced over the OpgB protein, were further characterized. Protein fusion points were downstream of amino acids 164 (P 164 ), 228 (P 228 ), 307 (P 307 ), 371 (P 371 ), 446 (P 446 ), 529 (P 529 ), 574 (P 574 ), 652 (P 652 ) and 747 (P 747 ) (i.e. after transmembrane segment 3, see Fig. 1 ). This random procedure did not give a fusion in the first 163 amino acids. Two opgB-blaM fusions were then generated by direct cloning into restriction sites (see Methods) with fusion points downstream of amino acids 41 (P 41 ) and 97 (P 97 ) (i.e. at the end of the predicted transmembrane segments 1 and 2 respectively, see Fig. 1 ). Ampicillin resistance conferred by these two fusions indicated that the b-lactamase moieties were periplasmic and cytoplasmic respectively (Fig. 1) . To confirm the location of each fusion protein, crude extracts were prepared from cells of strain NFB732 harbouring the corresponding plasmids and the b-lactamase activity was determined in the supernatant (soluble activity) and the pellet (insoluble membrane-bound activity) after centrifugation at 150 000 g for 2 h as described previously (Loubens et al., 1993) . As expected, most of the b-lactamase activity was recovered in the pellet for the two first fusion proteins (89 % and 83 % for P 41 and P 97 respectively). Surprisingly, most of the b-lactamase activity was recovered in the supernatant for the nine other fusion proteins (99 %, 78 %, 73 %, 78 %, 84 %, 84 %, 76 %, 69 % and 87 % for P 164 , P 228 , P 307 , P 371 , P 446 , P 529 , P 574 , P 652 and P 747 respectively). Thus, only P 41 and P 97 were found to be membrane-bound. These results confirmed the topological orientation of the three membrane-spanning segments. All the fusions beyond amino acid 163 were found to be essentially soluble. These results suggested a proteolytic cleavage of OpgB.
Phosphoglycerol transferase II is encoded by opgB
Phosphoglycerol transferase II was initially characterized from soluble proteins extracted from 600 g (wet weight) of E. coli cells after several purification steps (Goldberg et al., 1981) . When opgB mutants were obtained, their phosphoglycerol transferase II activities were determined by the phosphoglycerol cyclase test on total soluble proteins in crude extracts without subsequent purification steps. The activity was found to be similar in the mutant strains and in the wild-type strain (0.33 and 0.31 U mg 21 h 21 respectively), suggesting that two different genes encode the two phosphoglycerol transferases (Jackson et al., 1984) . In this work, we developed a micro-method using partially purified periplasmic extracts (see Methods). Three strains were compared for their phosphoglycerol cyclase activities (see Methods): strain 678, from which periplasmic extracts are particularly easy to obtain (Loubens et al., 1993) , an opgB derivative of strain 678 (NFB1814) and strain 678 harbouring plasmid pNF604 (opgB + ). Accumulation of tritiated cyclic phosphoglycerol increased linearly for at least 2 h in assays performed with extracts from strain 678 and strain 678(pNF604). The level of cyclase activity was 0.25±0.01 U (mg protein) 21 h 21 , 5.37±0.50 U (mg protein) 21 h 21 and 0.02±0.01 U (mg protein) 21 h 21 in periplasmic extracts from strain 678, strain 678(pNF604) and strain NFB1814 respectively. Whereas only a residual activity could be detected in NFB1814, a 25-fold increase in cyclase activity resulted from the introduction of the opgB + plasmid in strain 678. Because of the difference between our data and those published by Jackson et al. (1984) , crude extracts were also tested on our strains. Tritiated glycerol liberation activities were 0.70±0.01 U (mg protein) 21 h 21 and 0.30±0.01 U (mg protein) 21 h 21 for strain 678 and NFB1814 respectively. The apparent discrepancy between the data is most probably the result of a non-specific cytoplasmic activity present in crude extracts but absent from periplasmic extracts. Thus, the membrane-bound and the soluble phosphoglycerol transferase are encoded by the same gene.
Analysis of phosphoglycerol transferase II activity in vivo
From the model (Fig. 1) it is obvious that the cleavage should occur before the conserved sulfatase domain, just downstream of the third transmembrane segment. A deletion of plasmid pNF604 allowed the fusion of the two first codons of lacZ (encoded by the vector) with the codon corresponding to the last residue of the second transmembrane segment of OpgB (pNF721). The SignalP program (Nielsen et al., 1997, http ://www.cbs.dtu.dk/ services/SignalP/) allowed the prediction that signal peptidase I could recognize the remaining transmembrane segment as a signal sequence with a cleavage site between Ala 124 and Ser 125 . A similar construction was done with OpgB fused to BlaM downstream of amino acid 164, and its ampicillin-resistance phenotype indicated that the hybrid protein was expressed as a soluble periplasmic protein.
Plasmid pNF721 was introduced into strain BB2636 (a glycerol auxotroph that enables a specific and quantitative labelling of OPGs with [2-3 H]glycerol, and into its opgB derivative NFB758. OPGs were extracted from overnight cultures. In the presence of the plasmid, the OPG radioactivity remained null in the opgB background but was increased by 79 % in the wild-type background. These OPGs were further analysed by DEAESephacel chromatography (Fig. 2) . As described previously, OPGs of E. coli can be separated by this method in five subfractions corresponding to increasing charge-to-mass ratios (Lacroix et al., 1999, see Fig. 3 ). In strain BB2636(pNF721), the glycerol content of subfractions IV Fractions (4 ml) were collected and radioactivity was measured in aliquots.
and V was strongly increased (Fig. 2) . In conclusion, when the two first transmembrane segments of OpgB are deleted, a periplasmic protein is expressed that cannot complement a defect of phosphoglycerol transferase I activity but can increase significantly the phosphoglycerol substitution of OPGs in a wild-type background. These results demonstrate allotopic properties (Racker, 1967) of OpgB, which can use phosphatidylglycerol as a donor substrate only when anchored in the cell membrane, in complete agreement with the two-step mechanism proposed by Jackson & Kennedy (1983) .
Time-course of the phosphoglycerol substitution of OPGs
In the two-step model, OPGs still linked to or in the close vicinity of the membrane are substrates for the membranebound enzyme whereas OPGs liberated after a delay in the periplasmic space are substrates for the soluble enzyme. In order to test this model, [
14 C]glucose incorporation was followed in OPGs of strain DF214. This strain is defective for both phosphoglucose isomerase and glucose-6-phosphate dehydrogenase activities and can synthesize UDPglucose, and consequently OPGs, only when exogenous glucose is provided in the medium, thus allowing specific labelling of OPGs. DF214 was grown in low-osmolarity medium without glucose added until mid-exponential phase. D-[U-14 C]Glucose was then added to the medium and aliquots of the culture were taken up after 10 min, 3 h (exponential growth phase) and 6 h (stationary growth phase). OPGs were extracted and analysed by DEAESephacel chromatography (see Methods). The elution profiles for the three kinds of OPG preparations were markedly different. Actually, the time-course of phosphoglycerol substitution was followed from extracts containing only newly synthesized OPGs (10 min), from extracts containing a mixture of new and mature OPG molecules (3 h) and from extracts containing only mature OPG molecules (6 h) since OPGs are no longer synthesized during stationary growth phase (J.-P. Bohin & J.-M. Lacroix, unpublished results). As previously observed (Lacroix et al., 1999) , OPGs extracted from cells in stationary phase had various mass-to-charge ratios and were separated into five subfractions, representing 2 % (I), 16 % (II), 38 % (III), 30 % (IV) and 14 % (V) of the total, respectively (Fig. 3c) . OPGs extracted after 10 min of synthesis were much less anionic. Subfraction V was absent and subfractions I-IV represented 14 % (I), 40 % (II), 41 % (III) and 5 % (IV) of the total (Fig. 3a) . OPGs extracted after 3 h showed an intermediate distribution (Fig. 3b) . Newly synthesized OPGs (10 min) were further analysed. Subfractions II and III were submitted to an alkaline hydrolysis to remove succinyl residues linked to the backbone by ester linkages, then analysed once again by DEAE-Sephacel chromatography (amounts in subfraction IV were too low to allow accurate analysis). Sixty per cent of the treated subfraction II was now eluted in the neutral subfraction I while 40 % remained eluted in subfraction II; 60 % of the treated subfraction III was eluted in the neutral subfraction I and 40 % in subfraction II (data not shown). Thus, 14 % of the newly synthesized OPGs were neutral, 65 % were substituted by succinyl residues, and 33 % were substituted by phosphoglycerol residues (17 % being substituted by both substituents). Eighty per cent of the OPGs extracted from opgB cells in stationary phase are substituted by succinyl residues (Lacroix et al., 1999) and this level is probably lower in wild-type cells, where OpgB and OpgC are in competition for the same acceptor substrate. Thus, one can consider that succinyl substitution was already achieved in 10 min while phosphoglycerol substitution was a much slower process.
Concluding remarks
The opgB gene encodes a protein which is anchored in the cytoplasmic membrane and has the properties of phosphoglycerol transferase I. After post-translational modification (probable cleavage between Ala 124 and Ser 125 ), this protein becomes a soluble, periplasmic protein whose enzymic activity changes into phosphoglycerol transferase II. The cgmB gene, encoding a phosphoglycerol transferase catalysing phosphoglycerol substitution of OPGs in Sinorhizobium meliloti, was characterized by Wang et al. 14 C]glucose-labelled OPGs from strain DF214. Labelling was done for 10 min (a), 3 h (b), or 6 h (c). Ionic strength was increased by steps of 0.05 M NaCl at fractions indicated by the arrows. Fractions (4 ml) were collected and radioactivity was measured in aliquots. Peaks: I, neutral glucans; II-V, anionic glucans.
Phosphoglycerol substitution of OPGs in E. coli (1999) . Because CgmB of S. meliloti and OpgB of E. coli showed no significant similarity, and because CgmB is a soluble periplasmic protein, the authors suggested that CgmB may be more similar to phosphoglycerol transferase II. But, since in E. coli both phosphoglycerol transferase activities are encoded by the same gene, it appears that this hypothesis was not correct. In addition, no significant similarity was observed between Cgm and OpgC, two enzymes catalysing the succinyl substitution of OPGs in Brucella abortus (Roset et al., 2006) and in E. coli (Lacroix et al., 1999) respectively, or between these enzymes and both kinds of phosphoglycerol transferases. Thus, the various OPG substitution enzymes, which catalyse very similar reactions, have probably emerged from independent evolutions.
In E. coli, OPG synthesis occurs essentially at the innermembrane level in a complex of proteins including four membrane proteins, two periplasmic proteins and one cytoplasmic protein (Bohin & Lacroix, 2006) . Succinyl substitution occurs very early in the synthetic process and probably during the glucose backbone synthesis itself. A primary substitution by phosphoglycerol residues occurs at the same time. However, supplementary substitution, facilitated by a soluble periplasmic enzyme, is needed to achieve complete anionic substitution of OPGs.
